The London position statement of the World Congress of gastroenterology on biological therapy for IBD with the European Crohn's and Colitis Organization: When to start, when to stop, which drug to choose, and how to predict response

Geert R. D'Haens, Remo Panaccione, Peter D R Higgins, Severine Vermeire, Miquel Gassull, Yehuda Chowers, Stephen B. Hanauer, Hans Herfarth, Daan W. Hommes, Michael Kamm, Robert Löfberg, A. Quary, Bruce Sands, A. Sood, G. Watermayer, Bret Lashner, Marc Lémann, Scott Plevy, Walter Reinisch, Stefan SchreiberCorey Siegel, Stephen Targan, M. Watanabe, Brian Feagan, William J. Sandborn, Jean Frédéric Colombel, Simon Travis

Research output: Contribution to journalReview articlepeer-review

367 Scopus citations

Fingerprint

Dive into the research topics of 'The London position statement of the World Congress of gastroenterology on biological therapy for IBD with the European Crohn's and Colitis Organization: When to start, when to stop, which drug to choose, and how to predict response'. Together they form a unique fingerprint.

Medicine & Life Sciences